European
Renal Association – European Dialysis and Transplant Association
(ERA-EDTA)
in collaboration with
Renal Pathology Society (RPS)
December 8th 2003
Milan, Italy
by
J. Nagy
![]() |
|
Prof
Judit Nagy Second Department of Medicine and Nephrological Center Pecs University, Faculty of Medicine Pecs, Hungary |
A 30-year old Caucasian man, a violinist, was seen by his GP on December 2001 because of an upper respiratory tract infection with fever (body temperature 39.5°C) and with periumbilical pain. After a short symptomatic treatment he felt better. 2 weeks later, on January 2002 during a transatlantic flight he was found to have a purpuric rash and a moderate symmetrical oedema on his legs. After arriving he was referred to an outpatient department in the USA where they found minimal proteinuria, normal blood cell count, normal renal function and excluded deep vein thrombosis by Doppler ultrasound. They suspected vasculitis.
ANCA,
ds-DNA, HCV, HBV, HIV serology was negative. After 3 days bed rest he continued
his tour with his troop.
4 days later he was admitted to St. Luke Hospital, Jacksonville, FL, because
of a severe generalised oedema, palpable purpuric rash on both legs and
acute renal failure. Urinanalysis showed proteinuria (4.5 g/day) with irrelevant
urinary sediments with low S-albumin (24.6 g/l). S-creatinin was 247 µmol/l,
BUN: 20.1 mmol/l. He had a long history of cigarette smoking, pollen allergy
and Penicillin hypersensitivity.
He was referred to a nephrologist who (after exclusion of postrenal acute
renal failure by renal ultrasonography) indicated a renal biopsy. The pathological
picture showed severe diffuse and global mesangial cell proliferation, focal
segmental fibrinoid necrosis in the glomeruli by light microscopy and 3+
granular mesangial staining with IgA and 1+ staining with C3 by immunohistology.
C1q and C4 were negative.
Henoch-Schönlein purpura was diagnosed with nephrotic syndrome. He
was put on three days of high dose Solu-Medrol 1 gram per day and then titrated
down to prednisolon 60 mg daily . He was recommended to continue long-term
prednisolon therapy. After 5 days he came back to Hungary. He was on prednisolon
treatment for 1 week but because of the severe generalised oedema he was
referred to our Nephrological Center.
In February 2002 he was admitted with severe nephrotic syndrome with generalised
oedema, proteinuria (6.4 g/day), haematuria (50-90 dysmorphic red blood
cells per high-power field). His blood pressure was normal. S-creatinine:
281 µmol/l, creatinin clearance 48 ml/min. S-IgA 4.2 g/l, S-cholesterol
12.1 mmol/l, S-tryglicerid 3.63 mmol/l. Protein, calorie and salt-restricted
diet, ACEI, statin combined diuretic and methylprednisolon treatment 60
mg for further 6 weeks was moderately effective, albumin infusions with
Furosemide further decreased his generalised oedema. He became oedema-free
after 6-week treatment, proteinuria decreased to 0.5-1.0 g/day. His methylprednisolon
was slowly titrated down. But, because of no change in haematuria and in
renal function and moderate but permanent proteinuria we repeated the renal
biopsy.
Figure 1. Moderate to marked mesangial matrix expansion
can be seen in this glomerulus (PAS, x200).

Figure 2. The glomerulus shows moderate to severe sclerosis with fibrous crescent (PAS, x200).

Figure 3. Glomerular deposits of IgA show a global homogenous
and granular mesangial pattern by immunohistology (x400).

Figure 4. In addition to mesangial deposits, granular deposits
are seen in the GBM (x400).

Figure 5. Electron micrograph: glomerular capillary loop with numerous subepithelial and intramembranous electron-dense deposits.

Figure 6. Electon micrograph of a portion of a glomerulus
showing a great increase in the mesangial matrix and thickening of the basement
membrane.

Figure 7. This electron micrograph shows microtubular and
fibrillary deposits in the subendothelial layer of the basement membrane.
There was no amyloid deposition in the renal biopsy by congo red staining.
Oral glucose tolerance test (OGTT) showed impaired glucose tolerance (IGT).
There was no cryoglobulin in the circulation.
Further treatment was based on the clinical picture (mild proteinuria, slightly
elevated blood pressure, obesity, IGT, hyperlipidaemia, smoking, moderately
decreased renal function) and on the renal biopsy findings (diabetic and
sclerotic lesions in the glomeruli, interstitial fibrosis with round cell
infiltration). Diet (protein, calorie, salt restricted, native sugar free),
moderate regular exercise, stop smoking, ACEI, pentoxyphilline, statins.
At last check–up (Sept. 2003) he had no complaints, oedema-free, blood
pressure was normal (120/75 mmHg), blood-sugar 4.48 mmol/l, OGTT negative,
S-creatinine 96 µmol/l, S-cholesterol 4.17 mmol/l, S-tryglicerid 1.15
mmol/l, S-albumin 41.9 g/l, had miled proteinuria (albuminuria: 150 mg/day),
haematuria 5-8 red blood cells/high power field.
Summarizing the case: a severe Henoch-Schönlein syndrome with secondary
(?) diabetes "healed" with chronic glomerular and tubulointerstitial
histological damage and with mild alterations in laboratory examinations.
References
| 1. | Davin J. C., Ten Berge I. J., Weening J. J.: What is the difference between IgA nephropathy and Henoch-Schönlein purpura nephritis? Kidney Int, 2001;59:823-834. Pubmed Link |
| 2. | Meadow S. R., Scott D. G.: Berger disease: Henoch-Shcönlein without the rash. J. Pediatr. 1985;106:27-32. Pubmed Link |
| 3. | Coppo R., Mazzucco G., Cagnoli L. et al.: Long-term prognosis of Henoch-Schönlein nephritis in adults and children. Nephrol. Dial. Transplant. 1997;12:2277-2283. Pubmed Link |
| 4. | Pillebout E., Thervet E., Hill G., Alberti C., Vanhille P., Nochy D.: Henoch-Schönlein purpura in adults: outcome and prognostic factors. J. Am. Soc. Nephrol. 2002;13:1271-1278. Pubmed Link |
| 5. | D’Amico G., Napodano P., Ferrario F., Rastaldi M. P., Arrigo G.: Idiopathic IgA nephropathy with segmental necrotizing lesions of the capillary wall. Kidney Int. 2001;59:682-692. Pubmed Link |
| 6. | Saulsbury F. T.: Henoch-Schönlein purpura. Curr. Op. Rheumatol. 2001;13:35-40. Pubmed Link |
| 7. | Heaton J. M., Turner D. R., Cameron J. S.: Localization of glomerular "deposits" in Henoch-Schönlein nephritis. Histopathol. 1977;1:93-104. Pubmed Link |
| 8. | Szeto C. C., Choi P. C. L., To K. F, Li P. K. T., Hui J., Chow K. M., Leung C. B., Lui S. F., Mac-Moune Lai F.: Grading of acute and chronic renal lesions in Henoch-Schönlein purpura. Mod. Pathol. 2001;14:635-640. Pubmed Link |
| 9. | Emancipator S. N.: IgA nephropathy and Henoch-Schönlein syndrome. In:Heptinstall’s pathology of the kidney. Eds:Charles Jennette J., Olson J. L., Schwartz M. M., Silva F. G. Lippincott-Raven Publishers, Philadelphia, New York, 1998. pp 479-539. |